Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TEG002 |
Trade Name | |
Synonyms | TEG-002|TEG 002 |
Drug Descriptions |
TEG002 are T-lymphocytes engineered to express the Vgamma9Vdelta2 T-cell receptor, which may induce an antitumor immune response and tumor cell killing (PMID: 34575700). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C178253 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TEG002 | TEG002 | 0 | 1 |